The estimated Net Worth of Charles A Baker is at least $12.6 Million dollars as of 29 September 2017. Charles Baker owns over 2,000 units of Regeneron Pharmaceuticals stock worth over $12,555,950 and over the last 22 years Charles sold REGN stock worth over $0.
Charles has made over 23 trades of the Regeneron Pharmaceuticals stock since 2003, according to the Form 4 filled with the SEC. Most recently Charles exercised 2,000 units of REGN stock worth $37,220 on 29 September 2017.
The largest trade Charles's ever made was exercising 27,500 units of Regeneron Pharmaceuticals stock on 1 April 2003 worth over $146,575. On average, Charles trades about 4,532 units every 113 days since 2003. As of 29 September 2017 Charles still owns at least 11,000 units of Regeneron Pharmaceuticals stock.
You can see the complete history of Charles Baker stock trades at the bottom of the page.
Charles's mailing address filed with the SEC is RD 2 BOX 4830 PROVINCE LANE, , PRINCETON, NJ, 08540.
Over the last 22 years, insiders at Regeneron Pharmaceuticals have traded over $13,084,686,326 worth of Regeneron Pharmaceuticals stock and bought 8,562,481 units worth $2,539,854,760 . The most active insiders traders include Sanofi, Pharma Ag Novartis, and Leonard S Schleifer. On average, Regeneron Pharmaceuticals executives and independent directors trade stock every 8 days with the average trade being worth of $47,694,347. The most recent stock trade was executed by Marion Mc Court on 3 September 2024, trading 1,000 units of REGN stock currently worth $381,400.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Regeneron Pharmaceuticals executives and other stock owners filed with the SEC include: